S179 Regional and Racial Disparities in Pancreatic Cancer Mortality Among Adults With Diabetes: A 23-Year Analysis Using CDC WONDER (1999 to 2022)

Introduction: Diabetes is a significant risk factor for pancreatic cancer, with nearly half of pancreatic cancer patients diagnosed with diabetes. This study aims to estimate the mortality rate of pancreatic cancer (PC) in individuals with type 2 diabetes (T2DM). Methods: Mortality trends for adults aged ≥25 years with T2DM-associated PC were analyzed using CDC WONDER database, identifying deaths through ICD-10 codes C25 “Pancreas Malignant neoplasms” and E11 “T2DM”. Age-adjusted mortality rates per 100,000 were extracted, and annual percent changes with 95% CIs were calculated across demographic (sex, race/ethnicity, age) and geographic (state, urban-rural, regional) subgroups. Results: Between 1999 and 2022, 2807258 documented deaths were attributed to PC among diabetics in the United States. The overall AAMR for T2DM-related PC mortality increased in the United States from an adjusted rate 38.5 in 1999 to 74.4 in 2022 (APC: 2.98%; 95% CI: 2.61% to 3.39%). In Texas, AAMR increased from adjusted rate 38.2 in 1999 to 77.5 in 2022 (APC: 2.89%; 95% CI: 2.35% to 3.47%). Men had consistently higher AAMRs than women (92 vs 60.6). The AAMR in United States men increased from 45.3 in 1999 to 92 in 2022 (APC: 3.15%; 95% CI: 2.79% to 3.57%). The AAMR in United States women increased from 33.7 in 1999 to 60.6 in 2022 (APC: 2.47%; 95% CI: 2.05% to 2.92%). The non-Hispanic (NH) American Indian or Alaska Native population had the greatest AAMR (117.7), followed by the NH Black or African American (89.3) and Hispanic or Latino population (87.6). Lower-risk groups were NH White (71.1) and NH Asian or Pacific Islander (62.4). AAMR also varied by region (West: 99.6; Midwest: 78.2; South: 68.6; Northeast: 51.2). Non-metropolitan areas had higher AAMR (small metro: 82.4; non-core areas: 87.9; micropolitan areas: 87.8) than metropolitan areas (large central metropolitan areas: 75.3; large fringe: 62.1). The states in the upper 90th percentile were Oregon, California, Idaho, Wyoming, Oklahoma exhibited an approx. Two-fold increase in AAMRs, compared to states falling in the lower 10th percentile Illinois, Louisiana, Georgia, South Carolina, New York. Conclusion: Mortality rates from diabetes mellitus type 2-associated pancreas cancer have risen overall in the U.S. over the past 2 decades. NH American Indian or Alaska Native, NH Black or African American, and Hispanic or Latino men remain at high risk, highlighting the need for further investigation into effective prevention and treatment strategies.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001127176.71989.cf
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S179 Regional and Racial Disparities in Pancreatic Cancer Mortality Among Adults With Diabetes: A 23-Year Analysis Using CDC WONDER (1999 to 2022)

Sidra Naz, Dharshni Ramar, Shazia Khan, Abhishek Jha et al.
The American Journal of Gastroenterology
Pancreatic and Hepatic Oncology Research
article

S179 Regional and Racial Disparities in Pancreatic Cancer Mortality Among Adults With Diabetes: A 23-Year Analysis Using CDC WONDER (1999 to 2022)

Sidra Naz, Dharshni Ramar, Shazia Khan, Abhishek Jha, Maitri Shah, Rajesh Chowdhary, Choudhary Ahmed Hasan Maqbool
article en

Abstract

Introduction: Diabetes is a significant risk factor for pancreatic cancer, with nearly half of pancreatic cancer patients diagnosed with diabetes. This study aims to estimate the mortality rate of pancreatic cancer (PC) in individuals with type 2 diabetes (T2DM). Methods: Mortality trends for adults aged ≥25 years with T2DM-associated PC were analyzed using CDC WONDER database, identifying deaths through ICD-10 codes C25 “Pancreas Malignant neoplasms” and E11 “T2DM”. Age-adjusted mortality rates per 100,000 were extracted, and annual percent changes with 95% CIs were calculated across demographic (sex, race/ethnicity, age) and geographic (state, urban-rural, regional) subgroups. Results: Between 1999 and 2022, 2807258 documented deaths were attributed to PC among diabetics in the United States. The overall AAMR for T2DM-related PC mortality increased in the United States from an adjusted rate 38.5 in 1999 to 74.4 in 2022 (APC: 2.98%; 95% CI: 2.61% to 3.39%). In Texas, AAMR increased from adjusted rate 38.2 in 1999 to 77.5 in 2022 (APC: 2.89%; 95% CI: 2.35% to 3.47%). Men had consistently higher AAMRs than women (92 vs 60.6). The AAMR in United States men increased from 45.3 in 1999 to 92 in 2022 (APC: 3.15%; 95% CI: 2.79% to 3.57%). The AAMR in United States women increased from 33.7 in 1999 to 60.6 in 2022 (APC: 2.47%; 95% CI: 2.05% to 2.92%). The non-Hispanic (NH) American Indian or Alaska Native population had the greatest AAMR (117.7), followed by the NH Black or African American (89.3) and Hispanic or Latino population (87.6). Lower-risk groups were NH White (71.1) and NH Asian or Pacific Islander (62.4). AAMR also varied by region (West: 99.6; Midwest: 78.2; South: 68.6; Northeast: 51.2). Non-metropolitan areas had higher AAMR (small metro: 82.4; non-core areas: 87.9; micropolitan areas: 87.8) than metropolitan areas (large central metropolitan areas: 75.3; large fringe: 62.1). The states in the upper 90th percentile were Oregon, California, Idaho, Wyoming, Oklahoma exhibited an approx. Two-fold increase in AAMRs, compared to states falling in the lower 10th percentile Illinois, Louisiana, Georgia, South Carolina, New York. Conclusion: Mortality rates from diabetes mellitus type 2-associated pancreas cancer have risen overall in the U.S. over the past 2 decades. NH American Indian or Alaska Native, NH Black or African American, and Hispanic or Latino men remain at high risk, highlighting the need for further investigation into effective prevention and treatment strategies.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 58%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.